272 related articles for article (PubMed ID: 30478965)
1. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
[TBL] [Abstract][Full Text] [Related]
2. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.
Artru F; Bou Saleh M; Maggiotto F; Lassailly G; Ningarhari M; Demaret J; Ntandja-Wandji LC; Pais de Barros JP; Labreuche J; Drumez E; Helou DG; Dharancy S; Gantier E; Périanin A; Chollet-Martin S; Bataller R; Mathurin P; Dubuquoy L; Louvet A
J Hepatol; 2020 Jun; 72(6):1052-1061. PubMed ID: 31953139
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
[TBL] [Abstract][Full Text] [Related]
5. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
[TBL] [Abstract][Full Text] [Related]
10. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
Mehraj V; Jenabian MA; Ponte R; Lebouché B; Costiniuk C; Thomas R; Baril JG; LeBlanc R; Cox J; Tremblay C; Routy JP;
AIDS; 2016 Jun; 30(10):1617-27. PubMed ID: 27045377
[TBL] [Abstract][Full Text] [Related]
11. DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure.
Du XX; Shi Y; Yang Y; Yu Y; Lou HG; Lv FF; Chen Z; Yang Q
Liver Int; 2018 Feb; 38(2):229-238. PubMed ID: 28640516
[TBL] [Abstract][Full Text] [Related]
12. The role of ST2 and ST2 genetic variants in schistosomiasis.
Long X; Daya M; Zhao J; Rafaels N; Liang H; Potee J; Campbell M; Zhang B; Araujo MI; Oliveira RR; Mathias RA; Gao L; Ruczinski I; Georas SN; Vercelli D; Beaty TH; Barnes KC; Chen X; Chen Q
J Allergy Clin Immunol; 2017 Nov; 140(5):1416-1422.e6. PubMed ID: 28189770
[TBL] [Abstract][Full Text] [Related]
13. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.
Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y
Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
Chen Y; Qian J
J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
[TBL] [Abstract][Full Text] [Related]
15. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
16. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
17. Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection.
Lukic R; Cupic M; Gajovic N; Jurisevic M; Mijailovic Z; Davidovic B; Kujundzic B; Joksimovic B; Arsenijevic N; Jovanovic I
J Infect Dev Ctries; 2020 May; 14(5):519-526. PubMed ID: 32525839
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 and alcoholic liver disease.
Huang YS; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):395-401. PubMed ID: 10418175
[TBL] [Abstract][Full Text] [Related]
19. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
[TBL] [Abstract][Full Text] [Related]
20. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
